Gulleroglu Kaan, Baskin Esra, Bayrakci Umut, Aydin Erdinc, Ozluoglu Levent, Moray Gokhan, Haberal Mehmet
Department of Pediatric Nephrology, Baskent University, Ankara, Turkey.
Exp Clin Transplant. 2013 Dec;11(6):562-4. doi: 10.6002/ect.2012.0241.
Hearing impairment is a frequent problem that can easily influence the quality of life for the individual. It may affect one's social and academic life. Knowledge regarding hearing impairment after renal transplant is sparse. It has been suggested that renal transplant improves hearing function. Potential ototoxic side effects may be related to immunosuppression with calcineurin inhibitors. In pediatric renal transplanted patients, we do not have enough information about this subject. We report 2 cases that developed sudden hearing loss after a renal transplant that was associated with high serum levels of tacrolimus.
Two renal transplanted children (a 15-year-old boy and a 17-year-old girl), in the fourth year of their follow-up after transplant, developed symptomatic bilateral sudden hearing loss. There was a marked hearing impairment for the higher frequencies between 4000 and 8000 Hz in pure-tone audiometry evaluation. Also, a decrease of speech understanding was found, but the patients were not conscious of this problem. Hearing loss in these patients was not associated with any known risk factors such as chronic renal disease, ototoxic drugs, or acoustic trauma. Sudden hearing loss occurred under high serum levels of tacrolimus, and after dosage correction of tacrolimus pure-tone audiometry ruled out hearing loss progression for each patient.
Awareness of this potential complication of tacrolimus may be helpful for early recognition and treatment.
听力障碍是一个常见问题,很容易影响个人生活质量。它可能会影响一个人的社交和学术生活。关于肾移植后听力障碍的知识很少。有人认为肾移植可改善听力功能。潜在的耳毒性副作用可能与使用钙调神经磷酸酶抑制剂进行免疫抑制有关。在小儿肾移植患者中,我们对此主题没有足够的信息。我们报告2例肾移植后发生突然听力丧失的病例,这与他克莫司血清水平升高有关。
两名肾移植儿童(一名15岁男孩和一名17岁女孩),在移植后随访的第四年,出现有症状的双侧突然听力丧失。在纯音听力测定评估中,4000至8000Hz之间的高频出现明显听力障碍。此外,发现言语理解能力下降,但患者并未意识到这个问题。这些患者的听力损失与任何已知风险因素无关,如慢性肾病、耳毒性药物或声学创伤。突然听力丧失发生在他克莫司血清水平较高时,在调整他克莫司剂量后,纯音听力测定排除了每位患者听力损失的进展。
认识到他克莫司的这种潜在并发症可能有助于早期识别和治疗。